Management ChangeJul 13, 2026, 08:02 AM
Geron Appoints Chinmaya Rath as Chief Business Officer
AI Summary
Geron Corporation announced the appointment of Chinmaya Rath as its new Chief Business Officer. Mr. Rath brings over 25 years of extensive U.S. and global biopharma leadership experience, including significant roles at Novartis, Cellworks, and GlycoMimetics. His appointment is expected to enhance the company's strategic insights and execution, focusing on maximizing the global value of RYTELO and evaluating opportunistic innovation to build a leading hematology company.
Key Highlights
- Geron Corporation appointed Chinmaya Rath as Chief Business Officer.
- Mr. Rath brings over 25 years of U.S. and global biopharma leadership experience.
- He previously held significant roles at Novartis, Cellworks, and GlycoMimetics.
- Instrumental in major U.S. launches across hematology and solid tumors.
- Appointment aims to maximize RYTELO's value and build a leading hematology company.
Price Impact
More from GERN